Despite being widely used after surgery for brain metastases in cancer patients, stereotactic radiosurgery (SRS) has not been proven to be effective in medicine's most important testing ground: a ...

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall ...

Adaptation of a modified Elixhauser comorbidity index to isolate the impact of body mass index on survival outcomes in patients with cancer in a large integrated healthcare system. This is an ASCO ...

ATLANTA — Stereotactic radiosurgery (SRS) alone should be the favored first-line radiation therapy option for cancer patients younger than 50 years of age who have a minimal number of brain metastases ...

Preoperative stereotactic radiotherapy (SRT) was just as safe as postoperative SRT for patients with resectable brain metastases. More patients treated with preoperative SRT completed both radiation ...

Brain metastasis: Incidence, trend analysis, and impact on survival using SEER database (2010-2020). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small ...

The Congress of Neurological Surgeons (CNS) has updated its guidelines on using emerging therapies to treat metastatic brain tumors, reflecting improvements in pharmaceuticals, radiation therapy ...

Patients with small-cell lung cancer (SCLC) will typically receive whole-brain radiotherapy (WBRT) even though they don't have identifiable intracranial disease because of the high incidence of ...

People who experience side effects from cranial radiation therapy may recover full neurocognitive function within months. (HealthDay News) — Many patients with brain metastases who experience initial ...